Astrazeneca prices €2.2bn MTN

Pharma major AstraZeneca Plc priced its euro medium-term notes at an aggregate price of €2.20bn ($2.53bn).

Proceeds from the issuance would be utilized for general corporate purposes and repayment of debt. 

The debt was issued in three tranches which are as follows:

  • €500m, five-year, fixed rate notes with a coupon of 0.25%,
  • €900m,  eight-year fixed rate notes with a coupon of 0.75%, and
  • €800m, twelve-year fixed rate notes with a coupon of 1.25%.

The notes would be issued to institutional investors outside the U.S., the company said.

Source: Nasdaq

Advertisements

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s